Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
Chronic kidney disease (CKD) is part of a number of systemic and renal diseases and may reach epidemic proportions over the next decade. Efforts have been made to improve diagnosis and management of CKD. We hypothesised that combining metabolomic and proteomic approaches could generate a more system...
Guardado en:
Autores principales: | Esther Nkuipou-Kenfack, Flore Duranton, Nathalie Gayrard, Àngel Argilés, Ulrika Lundin, Klaus M Weinberger, Mohammed Dakna, Christian Delles, William Mullen, Holger Husi, Julie Klein, Thomas Koeck, Petra Zürbig, Harald Mischak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a637c8923964918aad48ef242dfe71b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CKD273, a new proteomics classifier assessing CKD and its prognosis.
por: Ángel Argilés, et al.
Publicado: (2013) -
Urinary proteomics to support diagnosis of stroke.
por: Jesse Dawson, et al.
Publicado: (2012) -
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers.
por: Holger Jahn, et al.
Publicado: (2011) -
Proteomics of vitreous humor of patients with exudative age-related macular degeneration.
por: Michael Janusz Koss, et al.
Publicado: (2014) -
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
por: Shi-ang Qi, et al.
Publicado: (2021)